OUR 9TH YEAR OF PROVIDING PROPRIETARY CAPITAL MARKETS INTELLIGENCE ON THE CANNABIS / HEMP / PSYCHEDELIC SECTORS
Capital Raises
Capital Raises Summary
Each week, Viridian publishes insights and analysis on completed capital raise transactions in the prior week, focusing on all equity and debt deals. Our analysis includes:
- Summary
- Outlook
- Best & Worst Perfromers
Quick Links
YTD Analysis
Cannabis capital raises for 2022 were down 65.6% from 2021:
- Total Equity issuance is off 75.0%, and total debt issuance is down 53.1%.
- U.S. debt is down only 47.4%, while Canadian debt is down a more significant 76.4%.
- At 58.7% of total capital raised, debt remains the highest in history for comparable periods.
- Public companies accounted for 75.4% of total financing in 2022, down from 80.8% in 2021.
- The graph below shows that U.S. activity dominated capital raise in 2022, with 74.7% of all capital raised.
- International capital raises of $319.8M represented 7.4% of total capital raises, exceeding the previous record of 6.4% in 2019.
Market Commentary and Outlook
This Week Sector Focus
Capital Raises vs Stock Prices
